Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
IBIT looks set to lead the next leg of Bitcoin's bull market. Technical momentum, heavy ETF inflows, and renewed institutional adoption create a favorable setup. This trade idea lays out a concrete entry at $44.34, a stop at $36.00, and a target at $80.00 with a long-term horizon (180 trading days). Risk is real — if flows reverse or macro liquidit…
Options activity in Iberdrola (IBE) shows a defensive posture in the near term, with puts outnumbering calls by about 2.1 to 1, concentrated at the €19.50 strike that sits essentially at the current stock price. At the same time, notable call volume for December and a March 2027 call spread indicate selective medium-term upside interest above €20. …
Iamgold (IAG) has reported record production and benefited from sharply higher realized gold prices. With a market cap around $11.5B, strong liquidity ratios and a clear production outlook for 2026, the stock offers an asymmetric mid-term long opportunity. This trade idea lays out an entry at $20.50, a stop at $18.25 and an initial target of $24.00…
Methode Electronics stock fell sharply in pre-market trading after investors reacted negatively to fiscal 2027 revenue guidance that matched analyst estimates rather than exceeding them. The company reported solid quarterly revenue growth and an adjusted loss narrower than expected, but widening net losses, negative free cash flow, and adjusted EBI…
The Financial Action Task Force (FATF) says criminal exploitation of informal, non-bank settlement systems - including hawala and other similar service providers (HOSSPs) - is now a widespread international challenge. A new FATF report, compiled with input from member states, documents that these channels are processing proceeds from a broader set …
Stereotaxis' Genesis Robotic Magnetic Navigation system was used to treat over 70 arrhythmia patients at the University of Szeged within one month of launching their robotic cardiology program, marking Hungary's first such program and demonstrating rapid adoption and advanced treatment capabilities.
Piper Sandler has increased its second-half 2026 Brent crude oil price projection by $10 per barrel to $90/b, pointing to a persistent Middle East supply stalemate and substantial cuts to Russian refining capacity that have tightened the global oil market more than expected. The firm calls the change largely a mark-to-market move, highlights Q3 rea…
AGM Group Holdings Inc. announced that their full-stack AI storage solutions are gaining market traction, driven by rising demand for high-performance data storage used in large AI model R&D and cloud services. The company has started mass production of all-flash servers and has secured procurement agreements with enterprise and regional computing …
3 E Network Technology Group Limited announced a $1 million private placement led by its CEO, Dr. Tingjun Yang, to strengthen its AI strategy. The capital will support ongoing R&D and commercialization of AI computing chips and applications. Recent milestones include advancements in edge AI SoCs, cloud AI storage controllers, a green AI data center…
Fairfax (FRFHF) is trading at roughly 7.7x reported earnings and 1.25x book with a $37.5B market cap, a modest $15 annual dividend and a small public float. For patient, value-oriented traders willing to accept limited liquidity and underwriting volatility, the risk/reward looks attractive: buy around $1,673.47, target $1,950 and stop at $1,500 ove…
Emergent BioSolutions has completed a repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028, reducing the outstanding debt balance to approximately $364.7 million. The company executed this repurchase at an average price of 90.6% of face value, deploying about $68 million of cash, demonstrating disciplin…
Ambev (ABEV) combines steady cash generation, an attractive 5.6% yield, and recent margin improvement with a buyback program — qualities that can attract flows as Brazil’s election period increases risk aversion. Trade idea: buy ABEV at $3.03, target $3.45, stop $2.70, mid-term (45 trading days).
A group of app developers has filed a £2 billion ($2.7 billion) legal claim in London accusing Apple Inc of applying stricter app tracking rules to outside developers than to its own services. The suit, lodged at the Competition Appeal Tribunal, centers on Apple’s App Tracking Transparency feature introduced in 2021 and asserts the policy harmed bu…
Metlen Energy & Metals saw its shares climb 2.5% following the signing of a ten-year Power Purchase Agreement with Coca-Cola Tria Epsilon. The contract covers the full electricity output of a roughly 12 MW photovoltaic facility in Mikro Perivolaki, Velestino, expected to generate about 16.5 GWh annually. The arrangement aligns with Coca-Cola HBC's …
Broadcom delivered another blowout AI quarter (Q3 revenue $29.59B; AI chips $16.7B, +221% YoY) and guided to $34.8B for Q4. The business is re-rating toward an infrastructure-software + custom AI accelerator profile that supports higher multiples — but those multiples are already steep. This trade idea buys a controlled long with a clear stop, bett…
Vertiv's core power and thermal portfolio, a $15B backlog and a strategic acquisition announced 09/03/2026 create a high-conviction trade setup. Technicals show the stock has cooled off from lofty levels and fundamentals—free cash flow of $2.93B and 24% sales growth last quarter—support a mid-to-long-term rebound. Entry $258.00, stop $225.00, targe…
Saia, Inc. releases its less-than-truckload (LTL) shipment and tonnage data for July and August 2026, showing increases in shipments per workday, tonnage per workday, and weight per shipment compared to the same months in 2025. These gains indicate solid operational performance in the third quarter so far, though the company cautions actual results…
Dyne Therapeutics announced preclinical data supporting the development of four novel investigational therapies targeting Duchenne Muscular Dystrophy (DMD) mutations amenable to exon skipping of 44, 45, 53, and 55. These candidates, based on the same FORCE™ platform as their lead drug under FDA review, demonstrated promising in vitro and in vivo re…
Trevi Therapeutics announced that senior executives will participate in several major healthcare and IPF-related conferences in September 2026, presenting updates on their investigational therapy Haduvio™ (oral nalbuphine ER) intended to treat chronic cough associated with IPF, non-IPF ILD, and refractory chronic cough. The company highlighted the …
Eikon Therapeutics announced the appointment of Dr. Ching-Pin Chang as Executive Vice President and Chief Scientific Officer. Dr. Chang brings over 20 years of experience in academic medicine and biopharmaceutical drug discovery, having held key roles at Bristol Myers Squibb, Gilead Sciences, and MyoKardia. His extensive expertise in translational …
Electra Battery Materials Corporation is progressing with the construction of Canada’s only cobalt sulfate refinery in Ontario as part of its strategic plan to strengthen North America's critical minerals supply chain. The company is actively engaging with investors, industry participants, and government bodies through multiple September conference…
Rekor Systems, Inc. has terminated its two remaining long-term real estate leases in the US and Israel, resulting in elimination of ongoing rent obligations and generating over $2 million in annual cost savings. The company used $2.8 million in cash to reduce $10 million in lease liabilities, improving operating leverage and aligning cost structure…
TG Therapeutics announced that CEO Michael S. Weiss will participate in a fireside chat at the Cantor Global Healthcare Conference on September 9, 2026. The company is a commercial-stage biotech focused on treatments for B-cell diseases, with its FDA-approved drug BRIUMVI for relapsing multiple sclerosis.
Structure Therapeutics, a clinical-stage biopharmaceutical company focused on oral small molecule therapeutics for metabolic diseases, will participate in three leading healthcare investment conferences in September 2026, including Cantor Global Healthcare, Morgan Stanley Global Healthcare, and Bernstein’s Healthcare Forum. Management will hold fir…
Crescent Biopharma, a clinical-stage biotech company focusing on innovative cancer therapies, announced its management will present at the 2026 Cantor Global Healthcare Conference and Morgan Stanley Global Healthcare Conference in September. The presentations will highlight the company's pipeline developments including a PD-1 x VEGF bispecific anti…
